New therapeutic options for bone diseases
Volume: 171, Issue: 5-6, Pages: 120 - 125
Published: Jan 29, 2021
Abstract
In recent years, new treatment options for both common and rare bone diseases have null become available. The sclerostin antibody romosozumab is the most recently approved drug for the therapy of postmenopausal osteoporosis. Its anabolic capacity makes it a promising treatment option for severe osteoporosis. Other sclerostin antibodies for the treatment of rare bone diseases such as osteogenesis imperfecta are currently being investigated. For...
Paper Details
Title
New therapeutic options for bone diseases
Published Date
Jan 29, 2021
Volume
171
Issue
5-6
Pages
120 - 125
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History